睡眠辅助产品市场规模、份额、成长分析、按产品类型、按睡眠障碍、按分销管道、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球睡眠辅助市场规模为780亿美元，从2023年的822.1亿美元增长到2031年的1252.2亿美元，预计在预测期内（2024-2031年）复合年增长率为5.4%。 。

睡眠障碍会对日常功能产生重大影响，导致白天过度嗜睡，并加剧学术和工作环境、心理健康、人际关係以及心臟病和糖尿病等慢性疾病的风险。常见病症包括失眠、睡眠呼吸中止症、不宁腿症候群和发作性睡病。治疗选择范围从匹托利桑、Modafinil和Modafinil等药物到褪黑激素和Zaleplon等治疗和非处方补充品。儘管运动和环境控制等生活方式调整可以改善睡眠质量，但药物的潜在副作用和患者不依从率较高可能会阻碍睡眠辅助市场的成长。展望 2024 年，应对这些挑战对于寻求改善睡眠健康的市场相关人员和医疗保健提供者至关重要。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 专利分析
• 案例研究
• 客户和购买标准分析

睡眠辅助市场规模：依产品类型

• 市场概况
• 床垫和枕头
• 药品
  • 根据处方笺
  • 店面销售(OTC)
• 睡眠呼吸中止症装置
  • 正压呼吸器(PAP)设备
  • 自适应伺服通气 (ASV) 装置
  • 口腔矫正器
  • 面具及配件
• 睡眠研究所
• 其他产品
  • 睡眠追踪装置
  • 白噪音机

睡眠辅助市场规模：依睡眠障碍分类

• 市场概况
• 失眠
• 睡眠呼吸中止症
• 不宁腿
• 发作性睡病
• 梦游
• 其他睡眠障碍

睡眠辅助产品市场规模：依通路划分

• 市场概况
• 零售药房
• 医院药房
• 网路药房
• 睡眠诊所
• 其他的

睡眠辅助市场规模：依最终用户划分

• 市场概况
• 成人
• 孩子
• 老年人

睡眠辅助市场规模：依地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Merck & Co., Inc.（USA）
• Sanofi（France）
• Koninklijke Philips NV（Netherlands）
• Pfizer Inc.（USA）
• GlaxoSmithKline PLC（UK）
• SleepMed Inc.（USA）
• Cadwell Laboratories Inc.（USA）
• Natus Medical Incorporated（USA）
• Fisher & Paykel Healthcare（New Zealand）
• ResMed Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• AstraZeneca（UK）
• Takeda Pharmaceutical Company Limited（Japan）
• Vanda Pharmaceuticals Inc.（USA）
• Mylan NV（USA）
• Koninklijke Philips NV（Netherlands）

结论和建议

Global Sleep Aids Market size was valued at USD 78.0 billion in 2022 and is poised to grow from USD 82.21 billion in 2023 to USD 125.22 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

Sleep disorders significantly affect daily functioning, contributing to excessive daytime sleepiness and exacerbating challenges in academic and professional settings, mental well-being, interpersonal relationships, and the risk of chronic conditions like heart disease and diabetes. Common disorders include insomnia, sleep apnea, restless legs syndrome, and narcolepsy. Treatment options range from pharmaceutical solutions such as pitolisant, modafinil, and armodafinil to therapies and over-the-counter supplements like melatonin and zaleplon. While lifestyle adjustments like exercise and environmental control can enhance sleep quality, potential side effects of medications and high rates of patient non-adherence may hinder growth in the sleep aids market. As we approach 2024, addressing these challenges will be crucial for market stakeholders and healthcare providers aiming to improve sleep health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Aids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sleep Aids Market Segmental Analysis

Global Sleep Aids Market is segmented by product type, sleep disorder, distribution channel, end-user and region. Based on product type, the market is segmented into mattresses & pillows, medications, sleep apnea devices, sleep laboratories and other products. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking and other sleep disorders. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, sleep clinics and others. Based on end-user, the market is segmented into adults, children and elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sleep Aids Market

The primary impetus behind the expansion of the global sleep aids market is the evolving sleep patterns among people, driven by contemporary lifestyles. As individuals grapple with increased stress, demanding work schedules, and technology-induced sleep disruption, the need for effective sleep solutions has surged. Additionally, rising disposable incomes and enhanced healthcare access are likely to further fuel the demand for sleep aids over the coming years. This convergence of factors-modern living challenges and heightened health consciousness-positions the sleep aids market for robust growth in the foreseeable future, as consumers seek out products that promote better sleep quality and overall well-being.

Restraints in the Global Sleep Aids Market

The Global Sleep Aids market faces significant challenges due to the rising complexity of treating sleep disorders driven by advanced technological innovations. Moreover, the absence of adequate regulatory documentation for the prescription and utilization of sleep medications, coupled with improper settings on sleep devices, hampers effective treatment options. These issues contribute to a stagnation in market growth, as consumers and healthcare providers grapple with the limitations of current solutions. As a result, the potential for expansion in the sleep aids market is stifled, hindering advancements in product development and overall accessibility to effective treatment alternatives for individuals experiencing sleep disturbances.

Market Trends of the Global Sleep Aids Market

The Global Sleep Aids market is experiencing significant growth, driven by rising consumer awareness of sleep-related disorders and the increasing prevalence of issues such as restless leg syndrome and narcolepsy. Innovative products like sleep-inducing pillows and mattresses are gaining traction among health-conscious consumers seeking better sleep quality. The burgeoning demand for both pharmaceutical and non-pharmaceutical sleep solutions reflects a broader trend towards holistic wellness. As people continue to prioritize sleep as a critical factor in overall health, the market is poised for further expansion, generating substantial revenue opportunities for manufacturers and suppliers within the sleep aids sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Customer & Buying Criteria Analysis

Global Sleep Aids Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Mattresses & Pillows
• Medications
  • Prescription-Based
  • Over-The-Counter (OTC)
• Sleep Apnea Devices
  • Positive Airway Pressure (PAP) Devices
  • Adaptive Servo-Ventilation (ASV) Devices
  • Oral Appliances
  • Masks & Accessories
• Sleep Laboratories
• Other Products
  • Sleep Tracking Devices
  • White Noise Machines

Global Sleep Aids Market Size by Sleep Disorder & CAGR (2024-2031)

• Market Overview
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Sleep Walking
• Other Sleep Disorders

Global Sleep Aids Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Sleep Clinics
• Others

Global Sleep Aids Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Adults
• Children
• Elderly

Global Sleep Aids Market Size & CAGR (2024-2031)

• North America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • USA
  • Canada
• Europe (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SleepMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vanda Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations